Comparison Beam Therapeutics (BEAM) with Competitors
Beam Therapeutics (BEAM) industry is Biotechnology.
Profit Margin
BEAM-40.20%
Industry-0.13%
Upside-40.07%
Operating Margin
BEAM-337.80%
Industry-2073.25%
Upside+1735.45%
Debt-to-Equity
BEAM8.60%
Industry29.76%
Upside-71.09%
Free Cash Flow Yield
BEAM-11.72%
Industry-1.94%
Upside-9.77%
P/E
BEAM-48.79
Industry-18.88
Upside-2991.03%
P/S
BEAM20.53
Industry9.28
Upside+121.18%
P/B
BEAM2.90
Industry4.70
Upside-38.35%